Herbert Zeh is an Oncology physician. OpenAlex indexes 819 publications with 43,226 citations (h-index 110); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Surgical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5150 Centre Ave
Room 460
Pittsburgh, PA 152321309
Telephone
412-692-2852Provider last certified this registry record 5 Jun 2026.
Clinical trials
- Safety Study of Modified Vaccinia Virus to Cancer
Sponsor: David Bartlett
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Antidiarrheal microorganisms58.1%Creon100%Part D<11 patientsProton pump inhibitor41.9%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2010–2018 per NIH RePORTER. The latest:
- Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy
University of Pittsburgh at Pittsburgh
FY2018$319,550R01CA181450 - Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy
University of Pittsburgh at Pittsburgh
FY2017$319,550R01CA181450 - Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy
University of Pittsburgh at Pittsburgh
FY2016$319,550R01CA181450
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cell death in pancreatic cancer: from pathogenesis to therapy
Nature Reviews Gastroenterology & Hepatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”